行业组件数据 · 2026

活性药物成分

Active Pharmaceutical Ingredient (API) is the biologically active component in pharmaceutical drugs that produces the intended therapeutic effect.

技术定义与适配语境
典型 活性药物成分 会按材料、尺寸公差、适配关系和失效风险在 化学制造 中评估。

Active Pharmaceutical Ingredient (API) refers to the substance or mixture of substances in a pharmaceutical drug that is biologically active and responsible for the therapeutic effect. In pharmaceutical manufacturing, APIs are synthesized, extracted, or purified through controlled chemical, biological, or biotechnological processes to meet strict purity, potency, and stability standards. They form the core component of finished dosage forms such as tablets, capsules, or injectables.

查看完整规格 查看制造来源

组件规格

定义
Active Pharmaceutical Ingredient (API) refers to the substance or mixture of substances in a pharmaceutical drug that is biologically active and responsible for the therapeutic effect. In pharmaceutical manufacturing, APIs are synthesized, extracted, or purified through controlled chemical, biological, or biotechnological processes to meet strict purity, potency, and stability standards. They form the core component of finished dosage forms such as tablets, capsules, or injectables.
工作原理
APIs work by interacting with specific biological targets (e.g., receptors, enzymes) in the body to modulate physiological processes. Their efficacy depends on chemical structure, solubility, bioavailability, and pharmacokinetic properties. In manufacturing, APIs are produced under Good Manufacturing Practice (GMP) conditions to ensure consistency, purity, and compliance with regulatory standards.
材料
High-purity chemical compoundsbiologics (e.g.proteinsantibodies)or natural extracts. Common materials include small molecules (e.g.aspirinibuprofen)peptidesand recombinant proteins. Excipients are not included.
Purity
≥98% (typically 99-100% for critical APIs)
Potency
Specified in mg/g or IU/mg
Stability
Shelf-life ≥24 months under recommended storage
Particle Size
Controlled (e.g., 10-200 μm)
Moisture Content
<0.5%
Residual Solvents
Per ICH Q3C guidelines
标准
ISO 9001ISO 13485ICH Q7USPEPJP

行业分类与别名

活性药物成分 的常用贸易名称、技术标识和检索关键词。

APIActive Pharmaceutical Ingredientpharmaceutical manufacturingdrug substanceGMPpuritypotencyICH guidelinespharmaceutical engineering活性药物成分Active Molecule化学制造 活性药物成分

上级产品

该组件会出现在以下整机或工业产品中。

药用级原料药
药品制剂中产生治疗效果的纯化学物质
查看产品详情 ->

FMEA · 风险与缓解

诱因 → 失效模式 → 工程缓解

Inadequate process control during synthesis->Formation of toxic impurities exceeding limits->Implement process analytical technology (PAT), in-process testing, and strict adherence to ICH Q3A/B impurity guidelines
Poor storage conditions (temperature, humidity)->API degradation leading to reduced potency->Use controlled storage environments, stability studies (ICH Q1A), and real-time monitoring systems
Cross-contamination in multi-product facilities->API contamination with other substances->Employ dedicated equipment, closed systems, and rigorous cleaning validation per GMP

工业生态与工程逻辑

兼容对象
High-shear mixersFluid bed dryersReaction vesselsPurification systems (e.g., chromatography)Milling machines
可替换件
PfizerNovartisRocheMerck & Co.Johnson & JohnsonGeneric API manufacturers (e.g., Teva, Dr. Reddy's)
0
Contamination (e.g., cross-contamination, microbial)
1
Impurity formation
2
Potency variability
3
Stability degradation
4
Regulatory non-compliance

合规与检测

tolerance
Purity: ±0.5%; Potency: ±5% of label claim; Impurities: ≤0.1% for unknown, ≤0.15% for known (per ICH)
test method
HPLC, GC, NMR, mass spectrometry, titration, Karl Fischer for moisture, particle size analysis, dissolution testing

制造该组件的工厂

来自 CNFX 组件能力表的相关制造商资料。

添加你的工厂

制造商列表用于前期研究和供应商能力理解，不代表认证、排名或交易担保。

采购评估维度

不是客户评论，也不是实时热度。以下维度用于前期 RFQ 准备和供应商评估。

技术文档
4/5
制造能力
4/5
可检验性
5/5
供应商透明度
3/5

这些分值是采购评估维度示例，不代表真实客户评分、具体国家买家反馈或实时询盘。

相关组件

吸收剂颗粒
Absorber pellets are specialized chemical components used in industrial absorption systems to capture and remove specific gases or contaminants from process streams.
活性炭介质
Activated carbon media is a porous filtration material used to remove contaminants through adsorption in industrial filtration systems.
活性催化化合物
Specialized chemical catalyst for industrial polyurethane foam manufacturing that accelerates polymerization reactions.
活性催化材料
Active catalytic material is the core reactive substance in SCR catalysts that facilitates nitrogen oxide reduction through selective catalytic reduction.
活性成分载体
Active ingredient carriers for controlled release in daily chemical elastomer gels.
活性氧化物基质
Active Oxide Matrix is a specialized filtration component used in inclusion absorbers to remove impurities and contaminants from industrial fluids through chemical adsorption and catalytic oxidation.

常见问题

What is the difference between API and finished dosage form?

API is the active substance that provides therapeutic effect, while finished dosage form (e.g., tablet) includes API plus excipients for delivery, stability, and patient compliance.

How are APIs manufactured?

APIs are produced via chemical synthesis, fermentation, extraction from natural sources, or recombinant DNA technology, followed by purification, drying, and milling under GMP conditions.

What regulations govern API production?

API manufacturing follows ICH Q7 GMP guidelines, regional pharmacopoeias (USP, EP), and regulations from agencies like FDA (US) and EMA (EU).

我可以直接联系工厂吗？

CNFX 是开放目录，不是交易平台或采购代理。工厂资料和表单用于帮助你准备直接沟通。
CNFX Industrial Component Index · 化学制造

数据基础

CNFX 制造商资料、技术分类、公开产品信息和持续合理性检查。

初步技术归类
本页用于结构化准备研究、RFQ 和供应商评估，不替代买方自己的供应商资质审查、标准核验和技术批准。

请求制造能力信息： 活性药物成分

说明目标数量、应用场景、交期和关键技术要求，用于准备 RFQ 或供应商评估。

谢谢，信息已发送。
谢谢，信息已收到。

需要制造 活性药物成分?

对比具备该组件加工或装配能力的制造商资料。

创建制造商档案 联系我们
上一个组件
活性药物成分
下一个组件
流变改性剂
URN:CNFX:ME:UNIT:ACTIVE_MOLECULE